Gracell Biotechnologies to Participate in Oppenheimer 32nd Annual Healthcare Conference
10 mars 2022 16h30 HE
|
Gracell Biotechnologies Inc.
PALO ALTO, Calif. and SUZHOU, China, March 10, 2022 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Report Fourth Quarter & Full Year 2021 Financial Results on Monday, March 14, 2022
02 mars 2022 08h00 HE
|
Gracell Biotechnologies Inc.
PALO ALTO, Calif. and SUZHOU, China, March 02, 2022 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Citi 2022 Virtual Immuno-Oncology Summit
03 févr. 2022 08h00 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in B Riley Securities 2022 Virtual Oncology Conference
18 janv. 2022 08h00 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
17 nov. 2021 16h05 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies Reports Third Quarter 2021 Unaudited Financial Results and Provides Corporate Update
15 nov. 2021 07h30 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
02 nov. 2021 08h30 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Two Upcoming Virtual Investor Conferences
15 oct. 2021 08h30 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Upcoming Virtual Investor Conferences in September
26 août 2021 09h00 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corporate Update
17 août 2021 07h00 HE
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...